On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,852 KRW | -3.49% |
|
-6.61% | -43.62% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,400 KRW | -0.78% | -2.14% | 71.78M | ||
3,180 KRW | -1.24% | -2.15% | 509M | ||
2,090 KRW | +1.46% | -0.48% | 79.93M | ||
1,852 KRW | -3.49% | -6.61% | 32.56M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.62% | 32.56M | |
+17.28% | 122B | |
+21.59% | 115B | |
+20.84% | 26.64B | |
-22.38% | 19.91B | |
-17.08% | 16.32B | |
-44.74% | 15.52B | |
-19.46% | 15.49B | |
+59.87% | 14.83B | |
+2.37% | 13.67B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors